Articles From: Alnylam Pharmaceuticals Reports Third Quarter 2014 Financial Results and Highlights Recent Period Progress to Alphatec Holdings Announces Third Quarter 2014 Revenue and Financial Results


Alnylam Pharmaceuticals, Inc .
Sign-up for Alnylam Pharmaceuticals Reports Third Quarter 2014 Financial Results and Highlights Recent Period Progress investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its investigational RNAi therapeutic programs toward genetically validated targets in development for the treatment of cardiovascular metabolic diseases, including: ALN-PCSsc targeting PCSK9 for the treatment of hypercholesterolemia; ALN-AC3 targeting apolipoprotein C3 (apoC3) for the treatment of hypertriglyceridemia; and ALN-ANG targeting angiopoietin-like 3 (ANGPTL3) for the treatment of genetic forms of mixed hyperlipidemia and severe hypertriglyceridemia.
Sign-up for Alnylam Presents New Pre-Clinical Data on RNAi Therapeutic Programs for Cardio-Metabolic Diseases at American Heart Association Scientific Sessions 2014 investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the third quarter ending September 30, 2014 on Wednesday, November 5, 2014, after the U.S. financial markets close.
Sign-up for Alnylam to Webcast Conference Call Discussing Third Quarter 2014 Financial Results investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 33 rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 10:00 a.m. PT (1:00 p.m. ET) at the Westin St.
Sign-up for Alnylam to Webcast Presentation at 33rd Annual J.P. Morgan Healthcare Conference investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Credit Suisse 2014 Healthcare Conference on Wednesday, November 12, 2014 at 3:00 p.m. MST (5:00 p.m. EST) at the Arizona Biltmore in Phoenix, Arizona.
Sign-up for Alnylam to Webcast Presentation at the Credit Suisse 2014 Healthcare Conference investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Nomura Biotechnology Conference on Thursday, November 6, 2014 at 9:00 a.m. ET at the Mandarin Oriental in Boston.
Sign-up for Alnylam to Webcast Presentation at the Nomura Biotechnology Conference investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Oppenheimer 25 th Annual Healthcare Conference on Thursday, December 11, 2014 at 2:45 p.m. ET at the Crowne Plaza Hotel in New York City.
Sign-up for Alnylam to Webcast Presentation at the Oppenheimer 25th Annual Healthcare Conference investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2014 Deutsche Bank BioFEST on Tuesday, December 2, 2014 at 2:15 p.m. ET at the Four Seasons Hotel in Boston.
Sign-up for Alnylam to Webcast Presentations at Upcoming Investor Conferences investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will webcast its upcoming R&D Day live on the Investors section of the company’s website, www.alnylam.com .
Sign-up for Alnylam to Webcast R&D Day investment picks
2014/12/14
YAKUM, Israel , December 14, 2014 /PRNewswire/ -- Alon Blue Square Israel Ltd.
Sign-up for Alon Blue Square Israel Ltd. Announces Resignation of Co-Executive Officer, Limor Ganot investment picks
2014/10/30
Declares Quarterly and Special Cash Dividends Schedules conference call for October 31, 2014 at 12:00 p.m. Eastern DALLAS , Oct.
Sign-up for Alon USA Energy, Inc. Reports Third Quarter 2014 Results investment picks
DALLAS , Nov.
Sign-up for Alon USA Partners To Acquire Krotz Springs Refinery From Alon Energy investment picks
2014/10/29
Schedules conference call for October 31, 2014 at 10:00 a.m. Eastern DALLAS , Oct.
Sign-up for Alon USA Partners, LP Reports Third Quarter 2014 Results and Declares Quarterly Cash Distribution investment picks
Alorica , a worldwide leading provider of customer management outsourcing solutions, today announced it has signed an agreement to acquire several of West Corporation’s (NASDAQ: WSTC) agent services businesses for a consideration of $275 million.
Sign-up for Alorica Announces Strategic Acquisition of West Corporation’s Agent Services Businesses investment picks
SUNNYVALE, Calif., Oct.
Sign-up for Alpha and Omega Semiconductor to Announce Fiscal First Quarter 2015 Financial Results investment picks
SUNNYVALE, Calif., Jan.
Sign-up for Alpha and Omega Semiconductor to Announce Fiscal Second Quarter 2015 Financial Results investment picks
BRISTOL, Va.
Sign-up for Alpha Natural Resources Affiliates Settle Selenium Cases investment picks
- Third quarter 2014 revenue was $1.1 billion and adjusted EBITDA, including a $16 million pre-tax gain from sale of 3.1 million Rice Energy shares, was $54 million - Cost reduction initiatives resulted in excellent cost performance in the East - Amended and extended secured credit facility and established a new accounts receivable securitization facility - Fine-tuning 2014 guidance; increased shipment volumes, interest expense, and SG&A; lowered Eastern adjusted cost of coal sales by $2.00 per ton at the midpoint - In October, Alpha subsidiary entered into an asset purchase agreement to dispose of non-core assets for total consideration of approximately $86 million, including $75 million in cash - Total liquidity at nearly $2.3 billion, including more than $1.3 billion in cash and marketable securities BRISTOL, Va.
Sign-up for Alpha Natural Resources Announces Results for Third Quarter 2014 investment picks
CARLSBAD, Calif., Oct.
Sign-up for Alphatec Holdings Announces Third Quarter 2014 Revenue and Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Alnylam Pharmaceuticals Reports Third Quarter 2014 Financial Results and Highlights Recent Period Progress to Alphatec Holdings Announces Third Quarter 2014 Revenue and Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent